✦ LIBER ✦

Metaanalysis of Survival, Complications, and Imaging Response following Chemotherapy-based Transarterial Therapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma

✍ Scribed by Ray, Charles E.; Edwards, Anthony; Smith, Mitchell T.; Leong, Stephen; Kondo, Kimi; Gipson, Matthew; Rochon, Paul J.; Gupta, Rajan; Messersmith, Wells; Purcell, Tom; Durham, Janette

Book ID: 122361133
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 815 KB
Volume: 24
Category: Article
ISSN: 1051-0443
DOI: 10.1016/j.jvir.2013.03.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to chemotherapy predicts surviv

Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy

✍ Risa M. Small; Nir Lubezky; Einat Shmueli; Arie Figer; Dan Aderka; Richard Nakac 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Impact of Chemotherapy Response and Radi

Impact of Chemotherapy Response and Radiation Dose on Overall Survival in Patients With Inoperable Non-small Cell Lung Cancer Treated With Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy

✍ Grant, J.; Gomez, D.; Zhuang, Y.; Chang, J.; Komaki, R.; Fossella, F.; Gold, K.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

896 Poster Encouraging survival without

896 Poster Encouraging survival without increased toxicity in a phase II trial of induction chemotherapy followed by RSR 13 and concurrent radiation therapy in patients with locally advanced unresectable non-small cell lung cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB